{
    "version": "https://jsonfeed.org/version/1.1",
    "title": "Harvard Health Posts by Robert Goldstein, MD, PhD Feed",
    "home_page_url": "https://www.health.harvard.edu/authors/robert-goldstein-md-phd",
    "feed_url": "https://www.health.harvard.edu/authors/robert-goldstein-md-phd/feed/json",
    "language": "en-US",
    "icon": "https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg",
    "items": [{
            "id": "https://www.health.harvard.edu/blog/hiv-rates-rising-could-new-forms-of-prep-help-202106182501",
            "title": "HIV rates rising: Could new forms of PrEP help?",
            "url": "https://www.health.harvard.edu/blog/hiv-rates-rising-could-new-forms-of-prep-help-202106182501",
            "content_html": "Last year, approximately 1.7 million new HIV infections occurred worldwide, and rates of infection are also rising in parts of the US. While a daily pill known as PrEP can help prevent HIV, two new formulations could make it easier for a broader range of at-risk people to use.",
            "summary": "Last year, approximately 1.7 million new HIV infections occurred worldwide, and rates of infection are also rising in parts of the US. While a daily pill known as PrEP can help prevent HIV, two new formulations could make it easier for a broader range of at-risk people to use.",
            "date_published": "2021-06-18T06:30:00-04:00",
            "date_modified": "2021-06-18T06:30:00-04:00",
                        "authors": [                { "name": "Robert Goldstein, MD, PhD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/10942/conversions/d6ef4880-8869-487b-b275-14f42482eae2-thumb.jpg",

            "tags": [ "LGBTQ+ health","Sexual Health","Healthy aging and longevity","Immune and infectious diseases" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/uu-ending-stigma-and-empowering-people-living-with-hiv-2020042219583",
            "title": "U=U: Ending stigma and empowering people living with HIV",
            "url": "https://www.health.harvard.edu/blog/uu-ending-stigma-and-empowering-people-living-with-hiv-2020042219583",
            "content_html": "People living with HIV can suppress the virus by taking medication daily. If the level of virus in a person’s blood is suppressed successfully, research shows that the virus isn’t passed on to others. U=U means “undetectable equals untransmittable.”",
            "summary": "People living with HIV can suppress the virus by taking medication daily. If the level of virus in a person’s blood is suppressed successfully, research shows that the virus isn’t passed on to others. U=U means “undetectable equals untransmittable.”",
            "date_published": "2020-04-22T14:30:08-04:00",
            "date_modified": "2020-04-22T14:30:08-04:00",
                        "authors": [                { "name": "Robert Goldstein, MD, PhD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/10144/conversions/GettyImages-1069532100-thumb.jpg",

            "tags": [ "Men's Health","Immune and infectious diseases","LGBTQ+ health","Women's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prep-prevents-hiv-so-why-arent-more-people-taking-it-2019100417942",
            "title": "PrEP prevents HIV — so why aren’t more people taking it?",
            "url": "https://www.health.harvard.edu/blog/prep-prevents-hiv-so-why-arent-more-people-taking-it-2019100417942",
            "content_html": "PrEP (pre-exposure prophylaxis) is a daily medication taken to prevent HIV infection. While multiple studies show PrEP is effective, relatively few of those who might benefit are taking it. Will a 10-year initiative to reduce rates of HIV and a new formulation of PrEP help?",
            "summary": "PrEP (pre-exposure prophylaxis) is a daily medication taken to prevent HIV infection. While multiple studies show PrEP is effective, relatively few of those who might benefit are taking it. Will a 10-year initiative to reduce rates of HIV and a new formulation of PrEP help?",
            "date_published": "2019-10-04T00:00:00-04:00",
            "date_modified": "2019-10-04T00:00:00-04:00",
                        "authors": [                { "name": "Robert Goldstein, MD, PhD" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/9920/conversions/GettyImages-1079492806-thumb.jpg",

            "tags": [ "Healthy aging and longevity","Immune and infectious diseases","LGBTQ+ health","Men's Health","Women's Health","Diseases & Conditions" ]
        }        
    ]
}